Source:http://linkedlifedata.com/resource/pubmed/id/11844864
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2002-2-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1533-4406
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
346
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
539-40
|
pubmed:dateRevised |
2004-12-18
|
pubmed:meshHeading |
pubmed-meshheading:11844864-Drug Approval,
pubmed-meshheading:11844864-Humans,
pubmed-meshheading:11844864-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:11844864-Pyridines,
pubmed-meshheading:11844864-Rhabdomyolysis,
pubmed-meshheading:11844864-United States,
pubmed-meshheading:11844864-United States Food and Drug Administration
|
pubmed:year |
2002
|
pubmed:articleTitle |
Cerivastatin and reports of fatal rhabdomyolysis.
|
pubmed:publicationType |
Letter
|